Sunday - May 17, 2026
NEJM Evidence Issues Research Articles in December 2023 Edition
November 30, 2023
WALTHAM, Massachusetts, Nov. 30 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its December 2023 edition (Vol. 2, No. 12):

Original Articles:

* Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes

* RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia

* Enz . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products